MedTrace Logo

Trial of Different Wound Dressings in Split-skin Grafted Third Degree Burns

NCT03674151 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-02-24

No results posted yet for this study

Summary

In plastic and reconstructive surgery, treatment strategies of second-degree burn wounds and split-skin grafted third-degree burn wounds aim at reducing infection and improving reepithelialization. Although previous studies indicate that burn patients benefit from newer wound dressings, only a few studies comparing different wound dressings can be found. Therefore, the aim of this study is to evaluate time to reepithelialization, pain, microbiology, handling and costs of different wound dressings in patients with split-skin grafted third-degree burn wounds.

Conditions

  • Split-skin Grafted Third-degree Burn Wound

Interventions

DEVICE

Silver Nylon dressing

Non-staining Silver Nylon dressing with a permanently plated metallic surface on split-skin grafted third-degree burn wound

DEVICE

Manuka-Honey

Manuka-Honey dressing on split-skin grafted third-degree burn wound

DEVICE

Povidone-Iod (PVP-Iod)

Povidone-Iod (PVP-Iod) dressing on split-skin grafted third-degree burn wound

DEVICE

Hydrogel

Hydrogel dressing on split-skin grafted third-degree burn wound

Sponsors & Collaborators

  • University of Luebeck

    collaborator OTHER

  • University Hospital Schleswig-Holstein

    lead OTHER

Principal Investigators

  • Tobias Kisch, MD · University Hospital Schleswig-Holstein

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03674151 on ClinicalTrials.gov